The Drug-Induced Respiratory Disease Website and App

Corticosteroids, systemic (oral, parenteral)

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

X.n

Tumor lysis syndrome (TLS)

Publications

Ripeau D, Ibarra ME, Moreno RP, Valentini L, Hernández A, Faín J, Seligra C, Tevez Echazú A, Picón A, Cardigni G

[Tumor lysis syndrome after the administration of corticosteroids in an adolescent without confirmed neoplastic disease. Case Reports].

Archivos argentinos de pediatria. 2022;120(1):e49-e53

Bubała H, Sońta-Jakimczyk D, Szczepańska M, Szprynger K

[Tumor lysis syndrome in the course of acute lymphoblastic leukemia as the consequence of prednisone monotherapy].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 2003;15(86):182-4

Wester JP, Breumelhof R, Geers AB, Meuwissen OJ

[Acute tumor lysis syndrome due to mono-therapy with a corticosteroid in a patient with non-Hodgkin lymphoma].

Nederlands tijdschrift voor geneeskunde. 1997;141(33):1621-3